These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24918813)

  • 1. Characterisation of familial colorectal cancer Type X, Lynch syndrome, and non-familial colorectal cancer.
    Shiovitz S; Copeland WK; Passarelli MN; Burnett-Hartman AN; Grady WM; Potter JD; Gallinger S; Buchanan DD; Rosty C; Win AK; Jenkins M; Thibodeau SN; Haile R; Baron JA; Marchand LL; Newcomb PA; Lindor NM;
    Br J Cancer; 2014 Jul; 111(3):598-602. PubMed ID: 24918813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risks of Colorectal Cancer and Cancer-Related Mortality in Familial Colorectal Cancer Type X and Lynch Syndrome Families.
    Choi YH; Lakhal-Chaieb L; Kröl A; Yu B; Buchanan D; Ahnen D; Le Marchand L; Newcomb PA; Win AK; Jenkins M; Lindor NM; Briollais L
    J Natl Cancer Inst; 2019 Jul; 111(7):675-683. PubMed ID: 30380125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of hereditary non-polyposis colorectal cancer: evidence of pathologic and genetic heterogeneity.
    Warden G; Harnett D; Green J; Wish T; Woods MO; Green R; Dicks E; Rahman P; Zhai G; Parfrey P
    Clin Genet; 2013 Dec; 84(6):522-30. PubMed ID: 23278430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinicopathological differences between familial colorectal cancer type X and sporadic cancer in an isolated area of spain.
    Medina-Arana V; Rahy-Martín A; Delgado-Plasencia L; Martínez-Riera A; León-Ayllón D; Rodríguez-Castellano D; Bravo-Gutiérrez A; Fernández-Peralta A; González-Aguilera JJ
    Colorectal Dis; 2016 Nov; 18(11):O388-O396. PubMed ID: 27671100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary colorectal cancer diagnostics: morphological features of familial colorectal cancer type X versus Lynch syndrome.
    Klarskov L; Holck S; Bernstein I; Nilbert M
    J Clin Pathol; 2012 Apr; 65(4):352-6. PubMed ID: 22287689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Familial Colorectal Cancer Type X (FCCTX) and the correlation with various genes-A systematic review.
    Nejadtaghi M; Jafari H; Farrokhi E; Samani KG
    Curr Probl Cancer; 2017; 41(6):388-397. PubMed ID: 29096939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X.
    Sánchez-Tomé E; Rivera B; Perea J; Pita G; Rueda D; Mercadillo F; Canal A; Gonzalez-Neira A; Benitez J; Urioste M
    J Gastroenterol; 2015 Jun; 50(6):657-66. PubMed ID: 25381643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of colonoscopic screening in Familial Colorectal Cancer Type X.
    Hatfield E; Green JS; Woods MO; Warden G; Parfrey PS
    Mol Genet Genomic Med; 2018 Nov; 6(6):1021-1030. PubMed ID: 30300963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison Between Familial Colorectal Cancer Type X and Lynch Syndrome: Molecular, Clinical, and Pathological Characteristics and Pedigrees.
    Xu Y; Li C; Zhang Y; Guo T; Zhu C; Xu Y; Liu F
    Front Oncol; 2020; 10():1603. PubMed ID: 32984025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Broadening risk profile in familial colorectal cancer type X; increased risk for five cancer types in the national Danish cohort.
    Therkildsen C; Rasmussen M; Smith-Hansen L; Kallemose T; Lindberg LJ; Nilbert M
    BMC Cancer; 2020 Apr; 20(1):345. PubMed ID: 32321466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Familial colorectal cancer type X syndrome: two distinct molecular entities?
    Francisco I; Albuquerque C; Lage P; Belo H; Vitoriano I; Filipe B; Claro I; Ferreira S; Rodrigues P; Chaves P; Leitão CN; Pereira AD
    Fam Cancer; 2011 Dec; 10(4):623-31. PubMed ID: 21837511
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer.
    Therkildsen C; Jönsson G; Dominguez-Valentin M; Nissen A; Rambech E; Halvarsson B; Bernstein I; Borg K; Nilbert M
    Eur J Cancer; 2013 Apr; 49(6):1226-35. PubMed ID: 23245329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and clinicopathological characteristics of mismatch repair-deficient colorectal carcinoma in early onset cases as compared with late-onset cases: a retrospective cross-sectional study in Northeastern Iran.
    Goshayeshi L; Ghaffarzadegan K; Khooei A; Esmaeilzadeh A; Rahmani Khorram M; Mosannen Mozaffari H; Kiani B; Hoseini B
    BMJ Open; 2018 Aug; 8(8):e023102. PubMed ID: 30166308
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of tumour molecular and pathology features to estimate colorectal cancer risk for first-degree relatives.
    Win AK; Buchanan DD; Rosty C; MacInnis RJ; Dowty JG; Dite GS; Giles GG; Southey MC; Young JP; Clendenning M; Walsh MD; Walters RJ; Boussioutas A; Smyrk TC; Thibodeau SN; Baron JA; Potter JD; Newcomb PA; Le Marchand L; Haile RW; Gallinger S; Lindor NM; Hopper JL; Ahnen DJ; Jenkins MA
    Gut; 2015 Jan; 64(1):101-10. PubMed ID: 24615377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequency of extracolonic tumors in Brazilian families with Lynch syndrome: analysis of a hereditary colorectal cancer institutional registry.
    da Silva FC; de Oliveira LP; Santos EM; Nakagawa WT; Aguiar Junior S; Valentin MD; Rossi BM; de Oliveira Ferreira F
    Fam Cancer; 2010 Dec; 9(4):563-70. PubMed ID: 20697958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hereditary non-polyposis colorectal cancer/Lynch syndrome in three dimensions.
    Kravochuck SE; Church JM
    ANZ J Surg; 2017 Dec; 87(12):1006-1010. PubMed ID: 26990828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Frequency of extra-colonic tumors in hereditary nonpolyposis colorectal cancer (HNPCC) and familial colorectal cancer (FCC) Brazilian families: An analysis by a Brazilian Hereditary Colorectal Cancer Institutional Registry.
    Oliveira Ferreira F; Napoli Ferreira CC; Rossi BM; Toshihiko Nakagawa W; Aguilar S; Monteiro Santos EM; Vierira Costa ML; Lopes A
    Fam Cancer; 2004; 3(1):41-7. PubMed ID: 15131405
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of 24 years national surveillance in different hereditary colorectal cancer subgroups leading to more individualised surveillance.
    Lindberg LJ; Ladelund S; Frederiksen BL; Smith-Hansen L; Bernstein I
    J Med Genet; 2017 May; 54(5):297-304. PubMed ID: 28039328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening of BMPR1a for pathogenic mutations in familial colorectal cancer type X families from Newfoundland.
    Evans DR; Green JS; Woods MO
    Fam Cancer; 2018 Apr; 17(2):205-208. PubMed ID: 28660566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.
    Dominguez-Valentin M; Therkildsen C; Veerla S; Jönsson M; Bernstein I; Borg A; Nilbert M
    PLoS One; 2013; 8(8):e71755. PubMed ID: 23951239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.